AstraZeneca (AZN): news on Saturday 17 October 2026

The 32 stories

Each headline's own score, strongest first. Links go to the publisher.

• +8.3 While the market panics about the FTSE 100, Citi just raised its AstraZeneca target to £186 Yahoo Finance
  Citi raises price target to £186.
• +7.0 AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership Pharmaceutical Technology
  Large AI-powered cardiometabolic partnership.
• +6.7 AstraZeneca agrees $40m AI drug discovery deal with insitro EMJ
  AI drug discovery deal agreed.
• +6.7 AstraZeneca, insitro Sign AI Drug Discovery Deal Contract Pharma
  AI drug discovery deal with insitro.
• +6.7 AstraZeneca partners with AI biotech insitro on liver, heart drugs Quartz
  Partnership with AI biotech on liver and heart drugs.
• +6.7 AZ and insitro ink AI collaboration to target MASH and cardiomyopathies BioXconomy
  AI collaboration targeting MASH and cardiomyopathies.
• +6.7 insitro and AstraZeneca strike up to $1.5B AI drug-discovery partnership for liver and heart disease Dealroom
  Up to $1.5B AI partnership for liver and heart disease.
• +6.7 AstraZeneca invests in AI against fatty liver and heart muscle disease Biostock
  Investment in AI for fatty liver and heart disease.
• +6.7 AstraZeneca strikes $1.5b AI drug discovery deal with Insitro Tech in Asia
  AI drug discovery deal with insitro.
• +6.7 EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca TradingView
  CHMP recommends extended indication for its H5N1 pandemic vaccine.
• +6.7 AstraZeneca PLC : Berenberg remains its Buy rating www.marketscreener.com
  Berenberg keeps Buy rating.
• +6.7 Health: AstraZeneca strikes $40 million AI drug discovery deal with insitro GDNOnline
  AI drug discovery deal with insitro.
• +6.7 AstraZeneca Partners with Insitro in USD1.5 Billion AI Drug Discovery Deal Medical Dialogues
  Billion-dollar AI drug discovery deal.
• +6.7 AstraZeneca teams up with insitro to harness AI for next-generation disease treatments Indian Pharma Post
  AI partnership for next-generation treatments.
• +6.7 AstraZeneca strikes 1.5 billion dollar AI drug discovery deal lifesciencesweden.se
  AI drug discovery deal worth 1.5 billion dollars.
• +6.7 AstraZeneca announces USD 1.46 billion insitro deal: AstraZeneca stock trades at EUR 148.70 - ad-hoc-news.de ad-hoc-news.de
  insitro deal announced; stock price noted.
• −6.7 Covid vaccine victim who lost the use of her hands after AstraZeneca jab was 'not disabled enough' for compensation Daily Mail
  Vaccine injury victim denied compensation; negative reputational story.
• +6.3 AstraZeneca, insitro Sign $40M AI Drug Deal Voice of Healthcare
  AI drug deal signed with insitro.
• +5.8 FTSE 100 AstraZeneca (LSE:AZN): Cancer Drugs Back Dividend Kalkine Media
  Cancer drugs seen supporting dividend.
• +5.8 AstraZeneca stock: RBC keeps GBp 14,500 target for AstraZeneca stock - ad-hoc-news.de ad-hoc-news.de
  RBC maintains high price target.
• +5.8 Fadnavis praises AstraZeneca for opening Mumbai office, thanks pharma company for COVID-19 vaccine The Statesman
  Maharashtra chief minister praises firm and its Mumbai office.
• +5.8 AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum Traders Union
  Technical analysis points to strong momentum.
• −5.0 Covid vaccine compensation scheme set for overhaul after Inquiry criticism BBC
  Vaccine compensation scheme overhaul after Inquiry criticism; reputational overhang.
• +5.0 Cote d'Ivoire and AstraZeneca announce a partnership to promote more equitable access to cancer care Novus Press Bulletin
  Cancer care access partnership with Côte d'Ivoire.
• +5.0 NIPER Raebareli & AstraZeneca India Partner to Strengthen Clinical Research Across India Digital Health News
  Clinical research partnership with NIPER in India.
• +5.0 AstraZeneca Pharma India announces new Mumbai corporate office, marking the next phase of growth through innovation EquityBulls
  Indian subsidiary opens new Mumbai office, signalling growth.
• +4.7 AstraZeneca Pharma India opens new Mumbai corporate office scanx.trade
  Indian unit opens new Mumbai corporate office.
• +4.2 AstraZeneca collaborates to identify novel drug targets Scientist Live
  Collaboration to identify novel drug targets.
• +3.3 AstraZeneca Pharma India receives ESG rating of 73 for FY26 scanx.trade
  Indian unit receives decent ESG rating.
• +3.3 AstraZeneca Pharma India ESG Rating 73 FY2025-26 Kalkine India
  Indian unit ESG rating of 73.
• +1.7 AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity? Yahoo Finance
  Shares have fallen but valuation framed as potential opportunity.
• +1.7 Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts Asianet Newsable
  Named among big pharma favouring pipeline expansion over buyouts; mild.